SD

Sorenson Development

North America, Utah, United States, Salt Lake City

Description

Sorenson Development

Investor Profile

Sorenson Development has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series C (33%)
  • Series E (33%)
  • Series D (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sorenson Development frequently co-invest with?

GB
North America, Massachusetts, United States, Framingham
Co-Investments: 1
WI
North America, Wisconsin, United States, Oshkosh
Co-Investments: 2
TPG-Axon Capital
North America, New York, United States, New York
Co-Investments: 1
WC
North America, New York, United States, New York
Co-Investments: 1
Unilever Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Jennison Associates
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Sorenson Development?

Merrimack

Cambridge, Massachusetts, United States

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

BiotechnologyHealth CarePharmaceutical
Series EApr 3, 2006
Amount Raised: $65,000,000
Merrimack

Cambridge, Massachusetts, United States

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

BiotechnologyHealth CarePharmaceutical
Series DApr 20, 2005
Amount Raised: $28,300,000
Merrimack

Cambridge, Massachusetts, United States

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

BiotechnologyHealth CarePharmaceutical
Series CMay 5, 2004
Amount Raised: $28,000,000